# Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

> **NCT01413113** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 6 (actual)

## Conditions studied

- Recurrent Thyroid Cancer
- Stage IVA Follicular Thyroid Cancer
- Stage IVA Papillary Thyroid Cancer
- Stage IVB Follicular Thyroid Cancer
- Stage IVB Papillary Thyroid Cancer
- Stage IVC Follicular Thyroid Cancer
- Stage IVC Papillary Thyroid Cancer

## Interventions

- **DRUG:** pazopanib hydrochloride
- **RADIATION:** iodine I 131

## Key facts

- **NCT ID:** NCT01413113
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-11
- **Final completion:** 2015-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-11-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01413113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01413113, "Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01413113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*